SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Oct 26, 2011
Document Date
Dec 19, 2011
Form Description
A preliminary proxy statement relating to a merger or acquisition
Filing Group
Mergers & Acquisitions
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC